• Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness, and oversight of laboratory test development.
• Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform
• Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Student Loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.
• Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform

Duration: January 1, 2008 to present

General Issues: Health Issues, Medical/Disease Research/Clinical Labs, Labor Issues/Antitrust/Workplace, Medicare/Medicaid

Spending: about $3,097,060 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Bureau of Labor Statistics (BLS), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Education - Dept of, White House Office, Office of Science & Technology Policy (OSTP), Natl Institutes of Health (NIH), Labor - Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Veterans Affairs - Dept of (VA), Congressional Budget Office (CBO), Government Accountability Office (GAO), Agency for Health Care Policy & Research, State - Dept of (DOS), U.S. Agency for International Development (USAID), Defense - Dept of (DOD), Medicare Payment Advisory Commission (MedPAC),, Veterans Affairs - Dept of (VA),, Office of Personnel Management (OPM),, Health Resources & Services Administration (HRSA),, Executive Office of the President (EOP)